Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways

We aim to evaluate the effects of auranofin, a known antioxidant, on hepatic steatosis, inflammation, and fibrosis, contributing to non-alcoholic steatohepatitis (NASH) development in vivo and in vitro. Transcriptome analysis of LX-2 cells was that expression patterns of genes changed by auranofin,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and molecular hepatology 2022-10, Vol.28 (4), p.827-840
Hauptverfasser: Lee, Seung Min, Koh, Dong Hee, Jun, Dae Won, Roh, Yoon Jin, Kang, Hyeon Tae, Oh, Ju Hee, Kim, Hyun Sung
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!